Common and Distinctive Intercellular Communication Patterns in Human Obstructive and Nonobstructive Hypertrophic

Christina J Codden1, Michael T Chin1,2

  • 1Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA.

Insights

Hypertrophic Cardiomyopathy (HCM) involves genetic changes affecting heart muscle. This study compares obstructive and nonobstructive HCM, revealing distinct cell communication patterns crucial for understanding disease progression and personalized treatment.

Area of Science:

  • Cardiology
  • Genetics
  • Bioinformatics

Background:

  • Hypertrophic Cardiomyopathy (HCM) is a common inherited heart disorder.
  • HCM presents with unexplained left ventricular hypertrophy, with or without left ventricular outflow tract (LVOT) obstruction.
  • Previous studies used single-nuclei RNA sequencing (snRNA-seq) in HCM, but direct comparisons between obstructive and nonobstructive phenotypes are lacking.

Purpose of the Study:

  • To perform a bioinformatic analysis comparing snRNA-seq data from obstructive and nonobstructive HCM patient samples.
  • To identify differentially expressed genes and distinct intercellular communication patterns in the two HCM phenotypes.

Main Methods:

  • Bioinformatic analysis of existing HCM snRNA-seq datasets.
  • Differential gene expression analysis.
  • Intercellular communication pathway analysis.

Main Results:

  • Identified 37 differentially expressed genes in cardiomyocytes and other cell types, linked to aging, muscle contraction, cell motility, and extracellular matrix.
  • Observed generally reduced intercellular communication in HCM, with specific alterations in pathways like growth factor binding and integrin binding.
  • Found increased communication in nonobstructive HCM involving adenylate cyclase binding, calcium channel activity, and serine-threonine kinase activity.
  • Noted increased communication between neurons/fibroblasts and immune cells, and enhanced endothelial cell communication, mediated by integrin-β1.

Conclusions:

  • Common and distinct molecular mechanisms contribute to the pathogenesis of obstructive and nonobstructive HCM.
  • Findings highlight specific cellular communication pathways that differ between HCM subtypes.
  • These insights offer potential for personalized management strategies tailored to different HCM phenotypes.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
80
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
103
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
14.7K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
80
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
52
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
57